Highlights
NASDAQ: VXRT       Vaxart Inc
Last Price Today's Change   Day's Range   Trading Volume
1.72   +0.04 (2.38%)  1.63 - 1.74  2,177,631

Overview

 
Avg Volume (4 weeks):5,807,110
4 Weeks Range:1.08 - 2.84
4 Weeks Price Volatility (%):
36.36%
52 Weeks Range:0.25 - 3.50
52 Weeks Price Volatility (%):
45.23%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Vaxart Inc, formerly known as Aviragen Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. Geographically all the business activity is functioned through the region of US.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3799  2095  243  2880 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.17-0.001 
 CELG 108.24+0.11 
 F 5.37+0.34 
 MFA 1.98+0.21 
 CCL 12.42+0.43 
 GE 7.14-0.16 
 BAC 24.86+1.41 
 AAL 12.51+1.18 
 OXY 15.36-0.20 
 ACHN 6.760.00 
Partners & Brokers